LIMN
Liminatus Pharma, Inc.Company with tickers: LIMN, LIMNW
CIK
1971387
CUSIP
53271X108
Shares Outstanding
44,877,633
13F Activity (30d)
11 filings
11 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-07-10 | Baek Richard JaiHwan |
Director | Other | 0 |
| 2025-07-10 | Lemons II Philip Wayne |
Director | Other | 0 |
| 2025-04-30 | Valetudo Therapeutics LLC |
10% Owner | Other | 6,169,406 |
| 2025-04-30 | Choi Beom Kyu |
Chief Technology Officer | Other | 0 |
| 2025-04-30 | Baek Ji Yeon |
Director | Other | 0 |
| 2025-04-30 | Dam Scott |
Chief Financial Officer | Other | 0 |
| 2025-04-30 | KH Feelux Co., Ltd |
10% Owner | Other | 4,000,000 |
| 2025-04-30 | Kim Chris |
Director, Chief Executive Officer, 10% Owner | Other | 6,169,406 |
| 2025-04-30 | Iris Acquisition Holdings LLC |
10% Owner | Other | 6,900,000 |
| 2025-04-30 | Lee Eun Sook |
Director | Other | 0 |
| 2025-04-30 | Lee Sang-Jin |
Head of Research & Development | Other | 0 |
| 2025-04-30 | Fernandez Nicholas |
Director | Other | 0 |
| 2025-04-30 | Yoo Byong Chul |
Chief Science Officer | Other | 0 |
Showing 1–13 of 13 transactions